Document is current

Any future updates will be listed below

Optimization of the effectiveness and cytocompatibility of Nigella sativa as a co-treatment for reducing methotrexate-related adverse effects

Crossref DOI link: https://doi.org/10.1007/s00580-019-03053-3

Published Online: 2019-10-14

Published Print: 2020-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark